With the increasing prevalence of chronic disease with aging, many older adults are treated concurrently for two or more diseases, a condition commonly referred to as a state of multimorbidity. 1,2) A recent report indicated that the prevalence of multimorbidity in Korea is up to 73%, 3) predominantly due to common diseases such as hypertension, osteoarthritis, and hyperlipidemia. Since medical management for these conditions requires medications for specific diseases, older adults with multimorbidity are likely to take multiple medications simultaneously. Consequently, polypharmacy, a geriatric condition defined as taking multiple medications (usually five or more per day) is a frequently encountered clinical condition in medical care for older adults. 4,5) Medical care for older patients, especially those with polypharmacy, should consider factors such as prescribing cascade, drugdrug interactions, drug-disease interactions, and potentially inappropriate medications (PIMs) for older adults. 6-9) Among these factors, the presence of PIMs is reportedly associated with increased adverse outcomes, including delirium, falls, functional decline, and mortality. Therefore, guidelines have recommended to reduce the use of or to replace PIMs with safer alternatives. 8-10) Moreover, the concept of deprescribing, an individualized therapeutic strategy that considers the risks and benefits of medications according to patient functional and comorbid status, has emerged with efforts to minimize adverse outcomes with polypharmacy. 11) Background: With the increasing prevalence of chronic disease due to aging, many older adults experience multimorbidity and polypharmacy. Medications with anticholinergic properties are particularly associated with adverse cognitive outcomes, including functional decline and mortality. We assessed the clinical impact of anticholinergic cognitive burden (ACB) on clinical outcomes of older patients acutely admitted to a single, hospitalist-operated medical unit of a tertiary hospital in Korea. Methods: This retrospective study reviewed electronic medical records of 318 patients aged 65 years or older admitted to the hospitalist-operated medical unit through the emergency department of Seoul National University Hospital. The analyzed clinical outcomes were the length of hospital stay, in-hospital mortality, unplanned intensive care unit admission, and unexpected readmission within 30 days. Results: The clinical outcomes did not differ between patients who took five or more drugs and those who did not. Patients with an ACB score of 3 or higher had a higher in-hospital mortality rate and longer hospital stay than those who did not. After adjusting for confounding factors, an ACB score of 3 or higher was an independent predictive factor for in-hospital mortality (odds ratio=3.09; 95% confidence interval, 1.18-8.06). Conclusion: ACB rather than the number of medications was associated with in-hospital mortality in acutely ill older patients. Further analytic and interventional studies are required to as...